SCHEMBL24453058

SCHEMBL24453058

N[C@@H](COC(=O)O)Cc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.57
MMP2 P08253 3/20 0.54
ALPI P09923 1/20 0.53
PKM P14618 1/20 0.53
PTGS1 P23219 1/20 0.53
XIAP P98170 1/20 0.53
SLC7A5 Q01650 1/20 0.53
SCN4A P35499 2/20 0.50
ANPEP P15144 1/20 0.50
SRR Q9GZT4 2/20 0.49
SLC1A3 P43003 1/20 0.49
SLC1A2 P43004 1/20 0.49
SLC1A1 P43005 1/20 0.49
SLC6A2 P23975 2/20 0.48
TAAR1 Q96RJ0 2/20 0.48
MAOA P21397 1/20 0.48
SLC6A4 P31645 1/20 0.48
SLC6A3 Q01959 1/20 0.48
SIGMAR1 Q99720 1/20 0.48
CYP2A6 P11509 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Solriamfetol SCHEMBL30929349 0.87 PKM (0.56) EPHX1MMP2ALPIPKMPTGS1
Solriamfetol SCHEMBL42525 0.87 PKM (0.56) EPHX1MMP2ALPIPKMPTGS1
Solriamfetol SCHEMBL30929348 0.87 PKM (0.56) EPHX1MMP2ALPIPKMPTGS1
Solriamfetol SCHEMBL42526 0.87 PKM (0.56) EPHX1MMP2ALPIPKMPTGS1
Solriamfetol SCHEMBL2739637 0.87 PKM (0.56) EPHX1MMP2ALPIPKMPTGS1
Solriamfetol SCHEMBL28413501 0.86 PKM (0.54) EPHX1MMP2ALPIPKMPTGS1
Solriamfetol SCHEMBL8430382 0.86 PKM (0.54) EPHX1MMP2ALPIPKMPTGS1
SCHEMBL28168081 0.86 MMP2 (0.55) EPHX1MMP2ALPIPKMPTGS1
Solriamfetol SCHEMBL4987496 0.86 PKM (0.54) EPHX1MMP2ALPIPKMPTGS1
SCHEMBL12691524 0.86 ALDH1A1 (0.55) EPHX1MMP2ALPIPKMPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220162159-A1 PROCESS FOR THE PREPARATION OF SOLRIAMFETOL AND SALT THEREOF ALIVUS LIFE SCIENCES LIMITED (IN) 2022-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162159-A1 PROCESS FOR THE PREPARATION OF SOLRIAMFETOL AND SALT THEREOF TST, SPR, STS EPHX1 2179/4885MMP2 2387/4885ALPI 3058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.